App to help high school students quit vaping
Official title: Vaping Cessation Among Youth: Evaluating the Kick-Nic! App
Run by Yale University · NCT06662305 · Data updated 2026-11-12
This study is testing whether the Kick-Nic! app can help high school students quit vaping better than just using a regular website with quitting resources.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 12 Years to 19 Years |
| Sex | All |
| Enrollment | 306 (estimated) |
| Sponsor | Yale University Academic / other |
| Locations | 1 site (New Haven, Connecticut) |
| Status | Recruiting |
| Started | January 7, 2025 |
| Main results expected | August 31, 2029 |
| Study ends | August 31, 2029 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT06662305 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are high school students aged 13-19 who are regular e-cigarette users and wish to quit.
✕Probably not a fit
Patients with unstable psychiatric conditions or those not currently using nicotine-containing e-cigarettes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of the Kick-Nic! app in helping high school students quit vaping. Participants will be randomly assigned to either use the app or access a control website with quitting resources. Over an 8-week treatment period, participants will engage with the app or website, with follow-up assessments at 1, 2, 3, and 6 months to measure abstinence rates. The study also includes qualitative interviews to gather feedback on the app's implementation and effectiveness.
Why it matters
Potential benefit: If successful, this app could significantly improve vaping cessation rates among youth.
How similar studies have gone: Other studies have shown promise in using mobile applications for smoking cessation, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. high school or middle school aged youth (12-19 years old), 2. regular current (past month) e-cig users using nicotine-containing e-cigs at least 1 day/week. 3. want to quit using e-cigarettes. 4. have a smartphone with data/WIFI plan in order to access and utilize the KickNic! app Exclusion Criteria: * Those who have non-stable (\<2 months) use of anxiolytics, antidepressants, and other psychostimulants or have a history of psychosis or any significant current psychiatric/medical condition that would increase risk will be excluded.
Where it's running
-
Yale University School of Medicine (Connecticut Mental Health Center)
New Haven, Connecticut, United States Recruiting
Study contacts
- Principal investigator: Suchitra Krishnan-Sarin, Ph.D. — Yale University School of Medicine, Dept of Psychiatry
- Study coordinator: Thomas Liss
- Email: thomas.liss@yale.edu
- Phone: 2034447545
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
YES-CAN!: a school-based program to prevent youth nicotine vaping
This program tests whether a year-long, student-led video curriculum in middle and high schools can help students avoid starting or stop nicotine vaping.
-
Comparing different forms of nicotine in vaping
This study is testing how different types of nicotine in vaping affect experienced users' cravings, withdrawal symptoms, and enjoyment while also looking at how their bodies process these forms of nicotine.
-
Pet imaging of sigma1 receptors in healthy adults
This study tests two sigma-1 radiotracers, to see how well they image the brain in healthy adults and how reliably the imaging measurements work.
-
Intradermal Flu Vaccine After All: Watching Immune Response in Skin and Blood
This study tests whether giving the seasonal flu shot into the skin (instead of muscle) changes the immune response in healthy adults, cancer patients about to start immunotherapy, and people with post-acute infection syndromes.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand
This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.